Eli Lilly

Chutes & Ladders: Eli Lilly loses its CEO, quickly promotes SVP to the role

Alzheimer’s biotech Alzheon to move once-failed drug into new PhIII

Lilly and Boehringer team up for experimental breast cancer trial pact

Axon’s Alzheimer’s vaccine hits Phase II as it seeks to prove efficacy

Chutes & Ladders: GSK vax head Slaoui to retire

Lilly, Incyte’s RA drug continues to prevent joint damage in long-term trial

Can Eli Lilly’s R&D game plan deliver a bottom-line rebound?

Abemaciclib data highlight Eli Lilly’s case on CDK 4/6

FDA grants Eli Lilly a priority review for soft tissue sarcoma drug

Lilly, Boehringer to start heart failure trials for Jardiance